Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

China Agrees to Accelerate Drug and Medical Device Approvals

publication date: Dec 22, 2014
Last week, at the end of an annual high-level meeting of US-China trade officials, it was announced that China agreed to speed up approvals of US drugs and medical devices. China said it would work off its backlog of drugs awaiting approval over the next two to three years, which probably means the CFDA will hire more staff. China also promised it would not ask US pharmas to conduct unnecessary clinical trials. Presumably, these upbeat statements are supported by specific steps, but officials did not release any further details in a post-meeting press conference. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital